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Abstract 
Decellularized extracellular matrices have been a growing area of interest in the 
biomedical engineering fields of tissue engineering and regenerative medicine.As these 
materials move toward clinical applications, the immune response to these materials will 
be a driving force toward their success in clinical approaches. Fully digested 
decellularized matrix constructs derived from porcine liver, muscle and lung were 
created to test the adaptive immune response. Hydrogel characterization ensured that 
the materials had relatively similar stiffness levels to reduce variability, and in vitro 
studies were conducted. Each individual construct as well as a gelatin control were 
plated with a co-culture of macrophages and T-cells to measure T-cell proliferation. In 
addition standard markers of inflammation through qPCR were measured in the 
macrophage group. Constructs were then placed into animals for 3 and 7 days in 
addition to a second group that received constructs for 21 days before secondary 
constructs were placed. These groups were then sacrificed following 3, 7 and 14 days 
to measure the residual and memory-like response of the constructs. Our results 
showed that t-cell proliferation was increased with decellularized constructs, particularly 
in tissue with higher DNA content. In vivo, animals with secondary treatments showed 
extended inflammatory response, driven by Th1 and Th17 polarization suggesting a 
memory-like response due to recognition of peptides in the constructs from secondary 
placements. 
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Chapter 1 – Introduction and Significance 
 
Significant strides have been made in the field of biomaterials and their application to 
tissue engineering in recent decades. While new materials have proven useful over a 
range of applications, many researchers are looking back toward the utilization of 
natural tissue structures and proteins as a method of healing injury and regeneration. 
Extracellular matrices are comprised of proteins produced by surrounding cells and 
provide a variety of key functions necessary for the tissues including support, signaling 
transduction and movement pathways. These proteins form a strict hierarchical 
structure that can be difficult to replicate in vitro, yet are vital to the healthy functions of 
a normal tissue. Extracellular matrices have become a popular biomaterial source for 
the development of novel tissue engineering and regenerative medicine approaches to 
a variety of conditions including cardiac, muscle and skin injuries. To apply these 
materials to a clinical setting, processes must be used to remove all cells and danger 
signals that could induce a negative immune response in the affected patient. These 
processes range in a variety of physical, chemical and enzymatic methods which all can 
greatly affect the mechanical and chemical properties of the matrix proteins following 
treatment. Careful process selection is necessary in order to have a final extracellular 
matrix product for the particular application a researcher or clinician needs. Extracellular 
matrix can be broken down in a more gentle method in order to maintain the strict 
protein structure seen in living tissue, or broken down more indiscriminately in order to 
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develop gels or novel structures while still maintaining similar protein content, albeit in a 
different structure.  
Extracullar matrix constructs consisting of fully broken down proteins have become a 
popular tool for research methods and potential clinical solutions. Through the utilization 
of the same protein content found in natural extracellular matrix, gel constructs have 
become adaptable applications for in vivo and in vitro studies for tissue engineering 
approaches. Stem cell research in particular has looked toward decellularized 
extracellular matrix to influence differentiation of the tissue or cell of choice through 
direct contact with the naturally occurring proteins and growth factors. These studies 
have shown promise in the ability of extracellular matrix to influence cells differentiation, 
and promote growth of specific tissue sets dependent on the extracellular matrix 
proteins introduced. These methods have even made the step toward clinical 
applications in areas such as skin regeneration, and future studies show promise to the 
beneficial capabilities of these matrix proteins.  
While in vitro and in vitro studies have shown promise, the effect of the indiscriminate 
breaking down of matrix proteins on the immune system has not been fully elucidated. 
Studies have shown that the extracellular matrix proteins may not have significant 
inflammatory effects on the innate immune system [1], however extensive research into 
the effect these protein constructs have on the adaptive immune system has not been a 
primary focus. The adaptive immune response occurs during and following the initial 
cleanup, where the innate immune system collects these degraded proteins and 
presents them to the adaptive immune system as a way to develop antibodies. Antibody 
production introduces further inflammation, and is the building blocks to the memory-like 
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system the body can deploy. With the small peptides and proteins from the extracellular 
matrix being collected in the high-inflammatory environment of injury sites, the adaptive 
immune system could collect these naturally found proteins and develop antibodies 
against them. This is generally the method that auto-immune diseases attack native 
tissue, usually due to a genetic defect in the protein. When the immune system 
recognizes these native proteins or peptides and antibodies for them are produced, 
increased inflammation at these proteins could occur. Further studies into the adaptive 
immune response to fully deconstructed decellularized extracellular matrices are 
needed to elucidate the interaction of the immune system with these broken down 
proteins.  
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Chapter 2 – Specific Aims 
 
 The specific aims of this project are to elucidate the interaction between fully 
digested decellularized extracellular matrix constructs and the adaptive immune 
response. The aims are split into an in vitro and in vivo  aim respectively.  
1.) In vitro - The objectives of the in vitro aim are to characterize the decellularized 
matrices to be used in the study and determine the immune response in vitro. 
Differences in each of our target tissue of interest may create differences in immune 
response. We hypothesize that digested decellularized matrices will influence 
macrophage and T cell activation. 
2.) In vivo- The objectives of the in vivo aim are to characterize the decellularized 
matrices to be used in the study and determine the immune response in vitro. 
Differences in each of our target tissue of interest may create differences in immune 
response. We hypothesize that digested decellularized matrices will influence 
macrophage and T cell activation. 
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Chapter 3 - Background 
 
3.1 Biomaterials 
As medical and scientific advances continue, novel materials are being utilized to 
treat new problems or challenges in human health. The use of materials in treating 
human condition has been widely applied for centuries but with a greater understanding 
of mechanisms of disease and injury, new materials are being applied in hopes to find 
cures or methods of regeneration for these diseases.  Biomaterials can range across a 
wide variety of materials, from metals and ceramics to polymers dependent on the 
needs of the affliction [2]. For example, in dental and bone applications metals or 
ceramics fulfill the necessary mechanical properties while eliciting a relatively low 
immune response [3]. In the case of organ damage or failure, novel replacement 
materials must be able to fulfill multiple criteria including function while maintaining a 
low toxicity to reduce the immune response.  These biomaterials can be utilized for a 
range of functions including tissue regeneration, drug release or functional tissue 
replacement. The success of these biomaterials is dependent on the ability to succeed 
in its primary function. In the case of bone and dental implants, the material must be 
able to undergo continuous stress while maintaining the integration at the site of 
implementation without failure [4], [5]. For drug delivery hydrogels, the biomaterial must 
be able to maintain its structure such that the delivery molecules can be released over 
an extended time at a set rate [6]. In the case of organ failure and replacement, novel 
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materials are being studied in hopes of developing a method for increasing the function 
in a diseased state, or even potential regeneration of the tissue of interest. 
While success of a biomaterial is primarily dependent on the ability to function, 
many factors can lead to the failure of the implant. Failure of an implant can lead to 
subsequent apoptosis of surrounding tissue, as well as buildup of fibrotic tissue and a 
limitation on organ function [7]. To prevent implant failure, the material must be able to 
maintain a microenvironment conducive to tissue function, including maintenance of 
immune system balance. In the case of organ transplantation, the host must be 
immune-compromised to reduce the risk of Graft-versus-Host Disease (GvHD). In the 
case of GvHD, the host immune system may recognize the transplanted tissue as 
genetically dissimilar, leading to subsequent attack by the host immune system [8]. This 
in turn leads to tissue apoptosis and an influx of pro-inflammatory factors that are not 
conducive to tissue function or survival.  
One biomaterial that is gaining interest as a treatment option is the utilization of 
decellularized matrix tissue to mimic the organ of interest as well as facilitate the 
regrowth of tissue [9], [10]. Current treatments being used in a clinical setting  primarily 
include autologous bone matrix, acellular skin treatments for burn victims and acellular 
heart valve procedures known as the Ross procedure [11]–[13]. With the major 
reduction in cells, the risk of host immunity recognizing the tissue as foreign is reduced. 
While the decellularized matrix alone is not capable of functioning as the replacement 
tissue there is hope that the scaffold of the tissue containing the similar extracellular 
components to its target treatment could lead to cell infiltration and regrowth.  Due to 
their high variability in source, as well as the ability to utilize decellularized tissues of 
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interest as a treatment option, decellularized matrices have become a biomaterial of 
choice in current biomedical research. 
 
3.2 Decellularized Extracellular Matrices 
Decellularized matrix and matrix components are becoming increasingly popular 
tools in research and clinical settings for numerous applications. The properties of the 
decellularized matrix is primarily dependent on the components of the extracellular 
matrix of the tissue of origin. In the case of skin, the primary proteins are collagen type I 
and elastin, which provide the tissue with the mechanical properties to stretch and 
undergo large deformation. Cartilage however is primarily proteoglycan and collagen 
type I and II to allow it to provide the dampening capabilities for joints. The 
decellularized matrices of each of these tissues would therefor provide differing 
mechanical properties and functions for their respective treatments.  
There are physical and chemical processes that effect the composition of the 
decellularized matrices following processing. The most common physical treatment 
methods to remove cellular components include rapid temperature change through 
freezing and electrical disruption. Rapid freezing leads to microcrystal formation in the 
cell membrane, leading to effective lysing of the cell. One other aspect of the freezing is 
that larger crystals can form, which can alter the conformation of the extracellular 
proteins allowing for changes in porosity to occur. Applied electrical pulses can disrupt 
the channels in the cell membrane causing an ion unbalance and subsequent cell 
apoptosis.  
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Chemical processes include washes of the tissue with ionic or non-ionic 
detergents. Ionic detergents such as sodium dodecyl sulfate (SDS) efficiently lyse cells 
and allow for soluble intracellular components to be rinsed away. Subsequent washes 
with acids and endonucleases break down nucleic acids and solubilize them to be 
removed with further washing. Non-ionic detergents such as Triton X-100 effectively 
disrupt the lipid-lipid interactions in cell membranes, leading to effective lysing and cell 
apoptosis.  While these treatments are effective at cellular removal, they can disrupt the 
protein structure [14]. SDS in particular has shown to bind and remove 
glycosaminoglycans (GAGs) and other proteoglycan structures [15]. This can effectively 
change the protein composition of the extracellular matrix in comparison to the native 
tissue, especially in tissues with high levels of GAGs such as cartilage or skin.  
Enzymatic treatments can also effectively decellularize tissues. In particular 
endonucleases are extremely effective at breaking down genetic content following cell 
lysing. Trypsin has also shown to be an effective enzymatic treatment for cell removal 
[16]. Due to the protein-cutting nature of enzymes, many enzymes can affect the protein 
structure of the remaining extracellular matrix. In treatments or studies that do not 
require intact protein structures, enzymes can provide efficient decellularization. In 
addition, collagenase and pepsin are enzymes that breakdown the extracellular matrix 
entirely, ensuring removal of cells from the entirety of tissues as well as tunable 
breakdown of protein structures [17].  
Due to the wide variety of applications specified decellularization processes can be 
utilized to ensure the post-treatment matrices contains the necessary parameters.  
3.3 Innate Immune Response 
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Immune response to these biomaterials can range across a spectrum dependent 
on the innate immune response reaction. The initial response to any sort of implanted 
biomaterial can dictate the subsequent immunological reaction, which can drive healing, 
fibrosis or tissue death [18]. These “first responders” include tissue-resident 
macrophages, neutrophils natural-killer cells and dendritic cells. Phagocytic 
macrophages and dendritic cells phagocytize pathogens or danger signals in the area 
and influence the rest of the immune system with signaling [19]. Danger signals include 
nuclear or cytosolic proteins that can be produced by damaged tissues and cells that do 
not undergo the standard apoptosis methods. Macrophages and dendritic cells 
phagocytize these biomolecules and can undergo a phenotype change toward a pro-
inflammatory response, producing cytokines such as TNFα, IL-1B and IL-6 that 
exacerbate the immune response [19]. Generally, activated macrophage phenotype is 
characterized by a pro-inflammatory response (M1), anti-inflammatory (M2) or naïve 
(MΦ) phenotype [20]. Pro-inflammatory macrophages are generally activated by 
pathogens, however in the presence of Danger Signal Molecules similar pro-
inflammatory responses can occur. Upon activation, macrophages can communicate 
with other innate and adaptive immune cells through cytokine production, 
microenvironment conditioning as well as antigen-presentation.  Pro-inflammatory 
activation leads to interleukin (IL) release which further recruits immune cells to the area 
prolonging the inflammatory response. Anti-inflammatory activation leads to production 
of cytokines which help control the immune response while also recruiting stem cells to 
promote healing. While convention dictates these states as the primary phenotypes of 
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macrophage activation, in reality the response is more along a gradient where immune 
cells may not fall directly into one of the phenotypes. 
Decellularized extracellular matrices can induce a response from the innate 
immune system that ranges from inflammatory to anti-inflammatory [21], [22]. Studies 
have shown differences in response dependent on the matrix purity, protein structure as 
well as mechanical properties. While the decellularized process removes the majority of 
cellular and genetic components, there can still be residual material which can lead to 
danger signaling in the innate immune system [23]. Recognition of these signals 
through Toll-like receptors (TLR) can lead to a signaling cascade producing a pro-
inflammatory response and the presentation of antigens. In addition to RNA and DNA, 
proteins and free cytokines can induce the same danger signal pathway in the innate 
immunity.  
3.4 Adaptive Immune Response 
In addition to stimulatory factor production, macrophages and dendritic cells also 
act as antigen presenting cells (APCs). Antigen presentation is one of the primary forms 
of communication between the innate and adaptive immune response. The adaptive 
immune system is comprised of cells from the lymphocytic lineage, T cells and B cells. 
These cells can bind to the presented antigens leading to activation. Depending on the 
type of antigen, different T cell activations can occur. Major-histocompatibility complex 
type I (MHC I) antigens generally are presented by APCs to denote whether the cell is 
foreign versus self. This can lead to an activation of CD8+ cytotoxic T cells, which attack 
foreign bodies and virus infected cells [24]. Major-histocompatibility complex type II 
(MHC II) antigens lead to activation of immunomodulatory CD4+ T helper cells. These 
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cells produce a variety of inflammatory and anti-inflammatory factors that can either 
prolong inflammatory response or attenuate it. T helper cells are commonly divided into 
four subsets, though continuing studies are showing there may be a more robust 
phenotypic layout [25], [26]. The four most prevalent subsets include type 1 helper cells 
(Th1), type 2 helper cells (Th2), type 17 helper cells (Th17) and T regulatory cells 
(Treg). Th1 cells produce interferon gamma (IFN-γ), a cytokine that promotes 
inflammation through activation of other innate and adaptive immune cells [27]. 
Typically released in bacterial or viral infection, IFN-γ activates macrophages toward the 
M1 phenotype increasing phagocytic activity and increasing CD4+ T cell activation 
through a positive feedback loop [28]. Th2 cells secrete anti-inflammatory factors IL-4 
and IL-13, which reduce macrophage activation and promote a more naïve lymphocytic 
phenotype [29]. Th17 cells release stimulatory interleukin 17 (IL-17), as well as other 
stimulatory cytokines including IL-21 and IL-22 [30]. IL-17 has been shown to be a 
regulator of the pathogenesis of numerous auto-immune disorders as well as effective 
stimulators of B-cell and T-effector memory cells [31]. Tregs are known as being 
modulators of inflammation by releasing IL-10, which has shown to reduce inflammatory 
phenotype in the innate immune cells [32].  
 B cells are the primary cells associated with the humoral immunity. B cell 
receptors bind to antigens, which they can then internalize through endocytosis before 
producing an MHC II antigen to present to T cells. Upon activation, CD4+ T helper cells 
then produce a positive feedback loop through stimulatory cytokine production leading 
to the rapid proliferation of these B cells. These B cells can activate become plasma 
cells which begin producing antibodies for this specific antigen allowing for natural killer 
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cells and macrophages to bind and phagocytize [33]. In addition, some of the B cells 
may stay dormant, producing the effective “memory” to the antigen to be activated again 
when encountered [34]. While typically thought of as primarily pathogen specific, B cells 
can produce antibodies for tissue specific proteins and peptides as well as potentially 
danger signals. These reactions form the basis for the pathogenesis of some 
autoimmune disorders [34], in which tissue-specific antigens are taken by the immune 
system, and antibodies for these antigens are produced leading to the attack of native 
tissue by the immune system.  
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Chapter 4 – Aim 1 
Biomaterial Characterization and In Vitro Immune Response 
 
Introduction 
 Decellularized matrices undergo many different processes to form the finalized 
material to be utilized in research or clinically. The different process can alter the 
physical and chemical composition of the decellularized matrix. While we focus on the 
utilization of digested gels, the overall mechanical properties can be adjusted with a 
backbone structure, in our case Methacrylated Gelatin (GelMA). Differences in stiffness 
can influence the immune response, as can the presence of danger signals. To 
determine the effectiveness of the decellularization process, DNA quantification can 
measure the relative DNA levels before and after the decellularization process. The 
objectives of this aim are to characterize the decellularized matrices to be used in the 
study and determine the immune response in vitro. Differences in each of our target 
tissue of interest may create differences in immune response. We hypothesize that 
digested decellularized matrices will influence macrophage and T cell activation. 
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Materials and Methods 
Extracellular matrix processing 
 Extracellular matrices were prepared using a modified method of Reing et al. 
[35], altering only two wash durations. Briefly, liver, lung and muscle pieces from a 
porcine animal model were transferred into Erlenmeyer flasks and underwent a series of 
chemical and enzymatic washes on an orbital shaker at 250 rpm. These consisted of 
three 2-h washes with 0.25% trypsin EDTA to provide thorough washing; three 15-min 
washes in deionized (DI) water; and one 15-h wash in 70% ethanol. This was followed 
by one 15-min wash in 3% hydrogen peroxide in DI water; two 15-min washes in DI 
water; and one 6-h wash in 1% Triton X-100 in EDTA/Trizma; and one 15-h wash in 
fresh 1% Triton X– 100 in EDTA/Trizma. The cartilage matrices were then washed three 
times for 15-min in DI water, followed by a 2-h wash in 0.1% peracetic acid (PAA)/4% 
ethanol, two 15-min washes in phosphate buffered saline (PBS), and two 15-min 
washes in DI water. Resulting pieces were frozen at 20 C for subsequent lyophilization 
before utilization in in vitro and in vivo testing. 
GelMA synthesis  
The detailed experimental procedure has been described previously [36]. In 
short, type A gelatin derived from porcine skin tissue was dissolved in calcium and 
magnesium free phosphate buffer solution, and the pH was adjusted with 5 M sodium 
hydroxide or 6 M hydrochloric acid. Subsequently, MAA (94%) was added dropwise to 
the gelatin solution under magnetic stirring at 500 rpm while maintaining 60° C. The 
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reaction proceeded for 3 h, and then the pH was readjusted to 7.4 to stop the reaction 
by quenching with phosphate buffer solution. After being filtered, dialyzed for 7 days 
in RO water, and lyophilized, the samples were stored at −20 °C until further use.  
Formation of ECM gels  
Therefore, ECM hydrogels were created using a modified version of the method 
of Freytes et al. [37]. Processed lung, liver and muscle fragments (approximately 2 mm 
x 2 mm) were frozen at 20 C overnight before lyophilization for 24 h. Lyophilized tissue 
was digested with 30 mg/mL pepsin in 0.01 N HCl for 48 h at RT to make ECM digests 
at a concentration of 10 mg (dry weight) per mL solution. ECM digest was stored at 20 
C until gels were created. ECM digests were adjusted to physiological pH in PBS with 
0.01 N NaOH, to form matrix gels with a final concentration of 6 mg (dry weight)/mL. 5% 
GelMA was added to the ECM gels to aid in gelation and to maintain an approximately 
equivalent stiffness level between all the groups. ECM/GelMA solutions were sterilized 
under UV light for approximately three hours before continuing the experiment. 0.05% 
LAP photoinitiator was added to the ECM gels. The matrix gels (500 µL) were then 
coated on 24-well plates or prepared for surgery in syringes. ECM digests were allowed 
to gel for 5 minutes under 405 nm Blue Light. Cartilage matrix gels were then hydrated 
with 500 µL Mg2+ and Ca2+-free PBS (Life Technologies, Carlsbad, CA, USA) for 1 h. 
PBS was then aspirated before cell culture experiments began. 
 
Hydrogel Rheology 
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One milliliter of pre-polymer ECM pre-gel and GelMA solution mixed with .05% 
weight/volume Lithium Phenyl(2,4,6-trimethylbenzoyl) phosphinate (TCI America) was 
pipetted into a two centimeter mold. Samples were then exposed to 9.6 mW/cm2 Blue 
light 405 nm for 180 seconds. Samples were then removed from the petri dish and 
tested using a TA Instruments Discovery HR-3 model rheometer. Samples were tested 
under conditions of an amplitude sweep from .01 to 10% strain at a frequency of 1 
rad/s. In addition, a frequency sweep from .1 to 10 rad/s was conducted at a constant 
strain of .05%. All tests were conducted at 37°C to best represent physiological 
temperature.  
Cell Isolation and culture 
Primary macrophages were isolated from femurs of 8-12 week-old female 
C57BL/6 mice (The Jackson Laboratory, Bar Harbor, ME) under VCU IACUC approval 
based on previously established protocols. Briefly, bone marrow cells were flushed from 
the femurs using Dulbecco's phosphate-buffered saline (Life Technologies, Carlsbad, 
CA). Red blood cells were removed from flushed bone marrow by addition of ACK 
Lysing Buffer (Quality Biological, Inc., Gaithersburg, MD). Cells were counted (TC20™ 
Automated Cell Counter, Bio-Rad Laboratories, Hercules, CA) and plated in a 175 cm2 
flask at a density of 500,000 cells/mL in 30mL RPMI 1640 media (Life Technologies) 
supplemented with 10% fetal bovine serum (Life Technologies), 50U/mL penicillin-50 
µg/mL streptomycin (Life Technologies), and 30ng/mL macrophage colony-stimulating 
factor (M-CSF, PeproTech, Rocky Hill, NJ). Cells were cultured at 37°C, 5% CO2, and 
100% humidity. Fresh media supplemented with M-CSF was added after four days. 
After seven days of exposure to growth factors, macrophages were passaged with 
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Accutase (Life Technologies) at room temperature for 1 hour and seeded onto ECM 
hydrogel coated plates for experimentation. 
Primary T cells were isolated from spleens removed from the same 8 week-old 
female C57Bl/6 mice. Naïve CD4+ T cells were then separated by negative selection 
using isolation columns (Milteny Biotec, San Diego CA). Briefly, spleens were crushed 
between two sterilized microscope slides to release cells, and red blood cells were 
lysed (ACK Lysing Buffer, Quality Biological, Inc.). A single cell suspension was 
magnetically labeled using a cocktail of biotinylated monoclonal antibodies and anti-
biotin microbeads labeling agents to deplete non-CD4+ splenocytes. Untouched 
isolated CD4+ T cells were then cultured in complete RPMI 1640 containing 10% FBS, 
1% L-Glutamine, 1% penicillin-streptomycin, and 0.1% 2-mercaptoethanol and activated 
for 48 hours in plates pre-coated with 5μg/mL anti-CD3e mAb (Biolegend) and treated 
by 2μg/mL anti-CD28 to promote proliferation before being used in experiments. 
In vitro Macrophage Activation 
To compare macrophage activation on the different Ti surfaces, secreted factors 
were quantified following 24 hours of culture. Differentiated macrophages were plated 
on Hydrogel coated well plates at a density of 50,000 cells/cm2. Media was removed 
and levels of pro- (IL1β, IL6, and TNFα) and anti- (IL4 and IL10) inflammatory markers 
for macrophage activation were measured by enzyme-linked immunosorbent assay 
(ELISA) based on manufacturer’s protocol and normalized to cell number. Cell number 
at was determined using DNA quantification assay and a standard curve plated with a 
known protein quantity plated in serial dilution. DNA levels were quantified in cell lysates 
using the Quant-iT™ PicoGreen dsDNA Assay Kit (Invitrogen, Life Technologies) as per 
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manufacturer protocol. RNA was isolated from plated macrophages with TRIzol (Life 
Technologies) following manufacturer’s instructions. Equal amounts (1000 ng) of RNA 
were reverse transcribed into cDNA for each sample (High Capacity cDNA Kit, Life 
Technologies). The resulting cDNA was used in real-time quantitative polymerase chain 
reaction (qPCR) reactions using Sso Universal Probes Supermix (Bio-Rad, Hercules, 
California) to measure mRNA quantities of pro and anti-inflammatory factors. 
In Vitro Co-Culture Model 
Interactions between T-cells and macrophages were examined using direct co-
culture experiments. In indirect co-culture experiments, macrophages were cultured on 
Ti surfaces for 24 hours at a density of 50,000 cells/well and media with secreted 
factors (conditioned media) were then collected and used to treat activated T-cells in a 
separate 24 well plate. For direct culture experiments, macrophages were grown on 
decellularized matrix hydrogels for 24 hours and then activated T-cells were added to 
the culture in a 1:1 ratio. These cells were allowed to interact for an additional 24 hours 
before media, and non-adherent T-cells were collected for analysis. To assess 
proliferation, CD4+ T-cells were treated with carboxyfluorescein succinimidyl ester 
(Yellow, Molecular Probes, ThermoFisher) during the direct co-culture with 
macrophages. Activated T-cells cultured with CD3 and CD28 (+) and unactivated T-cells 
cultured with only CD3 on GelMA were used as control groups. After 24 hours of 
interaction, cells were collected and analyzed by flow cytometry. Changes in CD4+ T-
helper proliferation were determined by flow cytometry using a CellTrace Yellow Cell 
Proliferation Kit (ThermoFisher Scientific, Waltham, MA). Stained cell suspensions were 
analyzed using the Guava® easyCyte 6-2L Benchtop Flow Cytometer (MilliporeSigma) 
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instrument with a total of 10,000 events were measured with three replicates for each 
measurement. Results were analyzed using guava Soft 3.1.1 InCyte software. 
Statistical Analysis 
A one-factor, equal-variance analysis of variance (ANOVA) was used totest the 
null hypothesis that the group means are equal, against an alternative hypothesis that at 
least two of the group means are different, at the α=0.05 significance level. Upon 
determination of a p-value less than 0.05 from the overall ANOVA model, multiple 
comparisons between the group means were made using the Tukey-HSD method. All 
statistical analysis was completed using GraphPad V5 software. 
Results and Discussion 
Gel Rheology 
Gel Rheometry conducted on the gel constructs was to ensure that the 
stiffnesses of the matrices were consistent such that there was not a strong difference. 
Differences in stiffness between matrix substrates have shown the ability to influence 
macrophage activation, fibrosis and healing [38]. Rheometry results across a frequency 
and amplitude sweep showed no significant differences between the GelMA group and 
hydrogel constructs. All storage modulus values fell between 200 and 300 Pascals 
(Figure 1), which is representative of extremely soft tissue such as brain tissue [39]. 
While precautions and testing can be conducted to ensure comparable mechanical 
properties, even slight differences have been shown to influence macrophage activation 
[40].  The stiffness provided allows for injection in in vivo studies, while maintaining its 
structure over time without risky solubilizing.  
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DNA Quantification 
To measure purity of the processed samples following treatment, DNA 
quantification was conducted before and after processing to quantify DNA removal in 
comparison to dry weight. Prior to decellularization, liver contained 70.415 ng/mg dry 
weight DNA, 26.243 ng/mg dry weight DNA in lung tissue and 8.0738 ng/mg dry weight 
DNA in muscle tissue. Following the decellularization process, 97-98% of all DNA 
content was removed from the tissue as shown in Table 1. These values are 
representative to those values found in literature and commercially [41], indicating that 
while the prevalence of Danger Signals is still a concern, it does fall within the approved 
range of acceptable values in research and industry. Microscopic image of pre-
treatment versus post-treatment shown in (Figure 3). 
 
Figure 1: Storage modulus values for each decellularized matrices 
treatment. 20 mm diameter pucks, 1 mL in volume of gel solution 
was used for each rheometry puck.  
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 DNA pre-processing (ng/mg 
dry weight) 
DNA post-processing (ng/mg 
dry weight) 
Total Percentage 
Reduction 
Liver 70.415 1.7061 97.58 
Lung 26.243 0.4038 98.46 
Muscle 8.0738 0.1152 98.57 
Table 1: DNA content prior to and following the decellularization processing. 
 
Macrophage Activations 
Following 24 hours of culture, expression of both pro and anti-inflammatory 
markers were measured by qPCR. No statistically significant changes in mRNA 
expression of pro-inflammatory markers Il-6, Tnfα or Il-1β between the liver, lung and 
muscle groups compared to the control (Figure 3). In addition, no statistical differences 
were seen in the comparisons of the treatment groups.  Similarly, no statistically 
significant changes in marker of anti-inflammatory Il-10 were seen. While on the surface 
A B C 
F E D 
Figure 2: Microscopic imaging of Muscle, Lung and Liver  
pre-processing (A,B,C) and post-processing (D,E,F) 
respectively. 
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these results may be surprising, many studies have shown that while danger signals 
and exogenous peptides from decellularization processing can cause inflammation, 
others have publicized immunomodulatory behavior by decellularized matrices [22], 
[42]. Following proper decellularization procedure, and reducing residual DNA content 
to a minimum, immune response can be reduced. Another potential explanation for the 
reduced immune response relies on the later time point (24 hours) of termination of cell 
culture experimentation. By 24 hours, macrophages may already be producing the pro 
or anti-inflammatory cytokines, and expression of these markers may have been 
reduced to closer to standard levels.  
 
Inflammatory mRNA Expression 
Figure 3: Changes in mRNA expression in primary macrophages plated on protein 
coated well plates (n=3). # p<0.05 vs control, @ vs Liver coating, & vs Lung coating. 
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Macrophage protein secretion drives further immune response by activation and 
recruitment following activation in response to exogenous peptides or danger signals. 
Significant differences in inflammatory cytokine production were seen following 24 hours 
of macrophage culture on each of the decellularized matrix protein coated well plates 
compared to control (Figure 4). Liver and muscle treatment groups showed the greatest 
increase in pro-inflammatory cytokine TNFα production in comparison to the control. 
Pro-inflammatory cytokine IL-6 was increased in all treatment groups, while IL-1β 
secretion showed no statistical differences between the groups and the control. Anti-
inflammatory cytokines IL-4 and IL-10 secretion was increased significantly in all 
treatment groups, with exception to IL-10 for the liver treatment with respect to the 
control. Overall, each of the treatment groups did have an affect on the initial cytokine 
secretion following direct plating on the decellularized matrices. Xenograft antigenicity 
can affect the murine immune system through recognition of certain peptide 
configurations as non-self or foreign material. In addition, residual DNA would increase 
this immune system activation, in comparison to an allograft or autograft where 
recognition of self would be more likely to occur.  
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Inflammatory Cytokine Production 
Figure 4: Changes in cytokine production from macrophages plated on ECM constructs (n=6). # 
p<0.05 vs control, @ vs. Liver treatment, & vs. Lung treatment. 
 
T cell activation 
To determine the incidence of antigen presentation by macrophages, 
macrophages and CD4+ T helper cells were co-cultured directly.  Following 24 hours of 
macrophage culture on each of the hydrogel coated plates, T cells were plated at a 1:1 
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ratio and allowed 48 hours for proliferation. Direct interaction between the macrophages 
and the T-cells on all treatment groups led to the ability to proliferate. Liver and muscle 
groups showed the highest incidence of T cell proliferation (CFSE low) of the treatment 
groups (Not Shown). GelMA and lung treatment T cells both showed the ability to 
proliferate, but the groups with higher inflammatory profiles produced greater rates of 
proliferation. This indicates that the decellularized matrix constructs are inducing 
macrophage presentation of Major Histocompatibility Class II antigens capable of 
activating CD4+ T helper cells which drive further adaptive immune response.  
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Conclusion 
Decellularized matrices are becoming a common tool for biomedical research 
and clinical applications. Due to their variability in structure and function, decellularized 
matrices of a multitude of tissue origins are being utilized to treat a variety of ailments. 
When decellularizing a matrix, care must be taken in choosing the best process to meet 
the scaffold function. Some studies focus on full tissue scaffolds, where full protein 
structure is maintained in hopes of allowing for re-infiltration by stem cells, and 
subsequent tissue regeneration. Other methods of decellularization utilize enzymes to 
further break down the protein structures, to fully reduce DNA content from the native 
tissue. In doing so, broken proteins may for peptide or protein configurations not 
typically found in the area, particularly for allografted or xenografted decellularized 
extracellular matrices. In our study, xenografted porcine tissue interacting with murine 
cells did induce a slight immune response. The decellularized liver, lung and muscle 
were all digested in pepsin prior to forming the ECM hydrogel construct, and as such 
were able to control the stiffness of the materials even though the native tissue 
stiffnesses varied greatly. The broken-down proteins could provide peptides that act as 
antigens in the MHC II antigen presentation macrophages. When phagocytized along 
with the remnant DNA and other danger signals, increases in TNFα and IL-1β lead to 
further macrophage activation as well as lymphocytic activation. T cells would then be 
activated, and from the MHC II antigen presentation, CD4+ T helper cell proliferation 
would occur as discovered in the co-culture study for the treatment groups. While 
inflammatory activation from decellularized matrices is not an entirely novel 
phenomenon, the influence on the adaptive immune system has not been elucidated, 
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and further studies will have to be conducted to confirm the mechanism of action for this 
activation pathway. Since it has been shown to be capable of activating macrophages 
and influencing the activation of CD4+ T helper cells, then could this activation via 
antigen presentation lead to further influence in the adaptive immune system and 
potentially a memory or auto-immune like response to these peptides? In clinical 
translation, the utilization of decellularized matrices would typically be for a disease-
state patient or model. The addition of digested extracellular matrices in an immune-
compromised system may lead to further presentation of digested proteins as antigens, 
leading to an enhanced adaptive immune response. In particular, the presentation of 
these antigens could lead to a memory or autoimmune-like response, particularly in 
cases that may require multiple treatments.  
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Chapter 5 – Aim 2 
Decellularized Matrices Effect on the Adaptive Immune Response In 
Vivo 
 
 
Introduction 
 From the previous aim we found that digested decellularized matrices did affect 
the immune response by macrophages, as well as activation of CD4+ T helper cells. 
With the proteins broken down to peptides, phagocytotic cells can engulf these peptides 
and present them as an antigen. This phenomena is more likely to occur if the likelihood 
of being recognized as self  vs. non-self is increased, such as for xenografts. The 
objective of this aim is to determine if the decellularized matrix constructs influence the 
adaptive immune response in vivo, and if repeated treatments lead to a lengthened and 
elevated immune response. When the adaptive immune response binds to antigens, 
they can then begin recruiting other cells such as B cells to replicate and produce 
antibodies for this antigen. In addition, B cells that contain the antibody can remain 
dormant as a memory cell, such that when activated by the specified antigen, they 
begin producing antibodies initializing the pro-inflammatory feedback loop. We 
hypothesize that digested decellularized extracellular matrix constructs induce a pro- 
inflammatory response in vivo, and shift the adaptive immune response toward pro-
inflammatory CD4+ subsets Th1 and Th17. In addition, repeated treatments of these 
constructs will further initialize and lengthen the pro-inflammatory response.  
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Materials and Methods 
Animals and Surgical Procedure 
For each study, 8 to 12-week female C57Bl/6 mice (The Jackson Laboratory, Bar 
Harbor, ME) were used. Animal handling procedures were performed under the 
approval of the Virginia Commonwealth University Institutional Animal Care and Use 
Committee (Protocol: AD10001108). Surgeries were performed between 8am and 12pm 
with mice randomly assigned to groups. 100 microliters of hydrogel sample were 
injected into the right femoral medullary canal of mice via a medial parapatellar 
arthrotomy as previously described [43]. Prior to procedures, mice were anesthetized by 
inhalation of 5% isoflurane gas in O2 and weighed (weight range 19-22g). Legs were 
prepared by shaving and cleaned with isopropanol and chlorhexidine. Mice were 
maintained under anesthesia by isoflurane gas to effect during preparation and surgical 
procedures. To place the hydrogel implant an 8 mm incision was made with a scalpel 
over the distal side of the knee. The knee ligaments and patella were then moved aside 
to expose the intercondylar notch of the femur. A 1 mm round dental burr was used to 
penetrate into the bone and access the medullary canal. Extracellular matrix hydrogel 
samples were then injected into the medullary canal. Three successful implants were 
performed for each hydrogel type. After implant placement, periosteal tissue was 
replaced and closed using resorbable sutures and surgical incisions closed with wound 
clips. Animals were treated with 0.01mg/kg buprenorphine SR LAB prior to recovery 
from anesthesia to relieve post-operative pain. Animals were monitored until initial 
ambulation and every 24 hours for the first 3 days following surgery. Secondary surgery 
animal groups were treated under the same protocol as previously mentioned following 
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21 days after initial surgery. For secondary treatment groups and the 14 day post 
surgery groups the staples were removed following 7 days post treatment. All animals 
were single housed following surgical procedure, with standard 12-hour light dark cycle 
and access to food and water ad libitum for the duration of the study. No signs of 
infection were present in this study. 
Flow Cytometry Analysis 
Changes in local cell populations were quantified by flow cytometry of bone 
marrow cells after 3, 7 or 14 days. Systemic changes were measured lymph nodes and 
spleens. Prior to staining, Fc receptors were blocked by incubation with CD16/32 
(BioLegend, San Diego, CA) and membranes permeabilized for transcription factor 
staining. Macrophage populations were measured in the bone marrow as well as liver 
with M1 and M2 positive antibody stainings [CD11b – FITC, CD86 (M1) – PE, CD206 
(M2) – APC].The ratio of b-cell and t-cell population was determined in lymph and 
spleens (T cell: PE-CD3, B cell: APC-CD29) (Biolegend). T cell populations were 
compared in lymph nodes, spleen and bone marrow (PE-CD3, APC-CD4, FITC-CD8). 
In addition T cell populations in the spleen and lymph nodes were identified by 
antibodies against T-helper cell marker CD4 (APC-CD4, Biolegend), as well as 
transcription factors of specific T cell populations [Th1 (PE-Tbet), Th2 (Alexa 488-
Gata3), Th17 (PE-RORγT, BD Biosciences), and Treg (Alexa 488-Foxp3)] (Biolegend). 
Cells were fixed and permeabalized for intracellular staining using Foxp3 Transcription 
Factor Staining Kit (eBiosciences, Thermofisher). Antibody concentrations were added 
based on manufacturer’s protocol. Stained cell suspensions were analyzed using the 
Guava® easyCyte 6-2L Benchtop Flow Cytometer (MilliporeSigma) instrument with a 
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total of 10,000 events were measured with three replicates for each measurement. 
Results were analyzed using guava Soft 3.1.1 InCyte software. 
Circulating Inflammation 
Serum was isolated from circulating blood collected 3, 7 and 14 days post 
material implantation by cardiac puncture. Following Cytokine levels were quantified by 
Enzyme-Linked immunoSorbant Assays (ELISAs) for pro-inflammatory (IL-6, TNF, IL-
1B, IL-17) and anti-inflammatory (IL-10) factors. Cytokine levels were analyzed and 
normalized to protein per mL serum based off of the dilutions applied to collected whole 
blood. Standard curves of the serial dilutions provided the method to quantify the 
amplification when reading at 450 nm.  
Statistical Analysis 
A one-factor, equal-variance analysis of variance (ANOVA) was used totest the 
null hypothesis that the group means are equal, against an alternative hypothesis that at 
least two of the group means are different, at the α=0.05 significance level. Upon 
determination of a p-value less than 0.05 from the overall ANOVA model, multiple 
comparisons between the group means were made using the Tukey-HSD method. All 
statistical analysis was completed using GraphPad V5 software. 
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Results and Discussion 
In Vivo Local Macrophage Activation 
To assess the effect of the decellularized extracellular matrix constructs on the 
local inflammatory microenvironment, macrophage activation was measured in the bone 
marrow at the site of hydrogel injection. In our first study, GelMA, liver, lung and muscle 
hydrogels were injected into the medullary cavity in one standard surgery. At three days 
post-surgery surface markers for inflammatory macrophages (CD86+) were significantly 
elevated in each treatment group in comparison to the GelMA and control groups, with 
liver and muscle both increasing the highest (Figure 5). The GelMA group saw no 
statistical difference in pro-inflammatory surface markers in comparison to the control. 
By 7 days, CD86+ cells were still significantly elevated in the decellularized matrix 
groups in comparison to the control and GelMA groups, though the percentage of 
inflammatory macrophages were attenuated in each case. Anti-inflammatory (CD206+) 
macrophages were elevated in each of the treatment groups including GelMA in 
comparison to the control 3 days following surgery. By 7 days, anti-inflammatory 
macrophages were still elevated, and have increased in comparison to the 3 day 
counterpart . This would be as expected, where the macrophage polarization shifts over 
time at the injury site from inflammatory (M1) to anti-inflammatory (M2) as the healing 
process commences.  
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In our second study, GelMA, liver, lung and muscle hydrogels were injected into 
the medullary cavity over two separate surgery procedures. Following the first surgery, 
the animal models were allowed to heal for 21 days post treatment, before undergoing 
the secondary surgery. This methodology helps highlight the memory response of the 
adaptive immune system. Surface markers for inflammatory and anti-inflammatory 
macrophages were quantified at 3, 7 and 14 days post secondary surgery to monitor the 
inflammatory reaction. At 3 and 7 days post secondary surgery, as seen in the single 
1st Surgery Groups 
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Figure 5: Local changes in macrophage phenotype populations in the bone marrow 
between single surgery treatment groups (n=3) at 3 and 7 days post-surgery. 
Inflammatory macrophages (M1) denoted by CD11b+ and CD86+ selection while 
Anti-inflammatory macrophages denoted by CD11b+ and CD206+ selection. # 
p<0.05 vs control, @ vs. GelMA treatment, & vs. Liver treatment, % vs. Lung 
treatment. 
 
Kegan Sowers 
34 
 
surgery treatment groups, the inflammatory macrophage phenotype was significantly 
increased in comparison to the GelMA and control group counterparts (Figure 6). In 
contrast, the GelMA groups showed significantly increased presence of inflammatory 
macrophages at 3 and 7 days post secondary surgery in comparison to the control, 
indicating that there is some inflammation associated with being a secondary surgery in 
comparison to the single surgery groups. At 14 days post-surgery, the difference 
between the GelMA and control group has been reduced to be no longer statistically 
significant, which would suggest that by 14 days post secondary surgery the 
inflammation has been resolved; however, the three extracellular matrix groups while 
reduced still maintain a significantly elevated level of M1 activation in comparison to the 
GelMA and control groups. This seems to suggest that while the inflammation may have 
been resolved following the first surgery after 21 days, the re-introduction of the 
decellularized matrices influenced the immune system to remain in a longer 
inflammatory state, presumably due to adaptive immunity. 
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2nd Surgery Groups 
Figure 6: Local changes in macrophage phenotype populations in the bone marrow 
between secondary surgery treatment groups (n=3) at 3, 7 and 14 days post-
surgery. Inflammatory macrophages (M1) denoted by CD11b+ and CD86+ selection 
while Anti-inflammatory macrophages denoted by CD11b+ and CD206+ selection. # 
p<0.05 vs control, @ vs. GelMA treatment, & vs. Liver treatment, % vs. Lung 
treatment. 
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In Vivo Cytokine Secretion 
In addition to macrophage activation, systemic inflammatory profile can be 
quantified by measure of cytokine levels found in whole blood. Pro-inflammatory (IL-1β, 
IL-6, TNFα and IL-17) cytokines and anti-inflammatory (IL-10) cytokine levels were 
measured through Enzyme-Linked Immunosorbant Assays, and normalized to a 
standard provided. In single surgery groups, decellularized matrix treatment groups had 
significantly elevated levels of all pro-inflammatory cytokines at 3 and 7 days post 
surgery (Figure 7). From 3 to 7 days, these inflammatory cytokine levels are reduced, 
suggesting that by 7 days inflammation has run its course, and a more naiive state of 
inflammation is in place. In the secondary surgery groups, we see extremely elevated 
levels of pro-inflammatory response at 3 days post surgery. Pro-inflammatory cytokine 
production of IL-1β, IL-6, TNFα and IL-17 all continue to rise through 7 days post 
surgery, and begin to attenuate by 14 days post surgery (Figure 8). This suggests a 
highly elevated as well as lengthened inflammatory response in the secondary surgery 
groups due to recognition of antigens. This leads to increased Th17 expression and 
enhanced IL-17 cytokine production.  
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Serum Cytokine Levels 1st Surgery 
Figure 7: Changes in systemic cytokine levels in circulating plasma for single surgery groups 
at 3 and 7 days post-surgery (n=3). # p<0.05 vs control, @ vs. GelMA treatment, & vs. Liver 
treatment, % vs. Lung treatment. 
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Serum Cytokine Levels 2nd Surgery 
Figure 8: Changes in systemic cytokine levels in circulating plasma for secondary surgery 
groups at 3 and 7 days post-surgery (n=3). # p<0.05 vs control, @ vs. GelMA treatment, & 
vs. Liver treatment, % vs. Lung treatment. 
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1st Surgery Bone Marrow Groups 
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Figure 9: Local changes in T cell populations in the bone marrow between single 
surgery treatment groups (n=3) at 3 and 7 days post-surgery. Th signifies T helper 
cell groups (CD4+) while Tc signifies cytotoxic T cell (CD8+) groups. # p<0.05 vs 
control, @ vs. GelMA treatment, & vs. Liver treatment, % vs. Lung treatment. 
Local T cell activation 
To measure the influence of the extracellular matrix treatments on the local 
adaptive immune system response, T cell populations were quantified in the bone 
marrow 3 and 7 days after our primary surgery group. 3 days following the primary 
surgery, both CD4+ T helper cells and CD8+ Cytotoxic T cells were elevated in 
decellularized matrix treatment and GelMA treatment in comparison to the control 
(Figure 9). By 7 days post treatment, CD4+ cells in GelMA treatment groups were no 
longer significantly elevated in comparison to the control groups. The three 
decellularized matrix groups all maintained significantly elevated T helper cell incidence 
at 7 days post surgery compared to the GelMA and control group suggesting that there 
is an elevated presence of MHC II antigen presentation in the area activating and 
proliferating CD4+ T cells.  
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In our secondary surgery groups, similar trends are followed as in the primary 
surgery study. At 3 and 7 days post surgery, decellularized matrix groups have severely 
elevated levels of CD4+ T helper cells and CD8+ Cytotoxic T cells (Figure 10). While 
cytotoxic T cells maintain elevated expression throughout in all groups, this can be an 
indicator of the pro-inflammatory subset of CD4+ cells being elevated. When activated 
to the Th1 subset, interferon-γ secretion leads to the proliferation of CD8+ T cells. At 3 
days post surgery the GelMA treatment group also is significantly elevated T-helper 
cells compared to control. This activation is no longer statistically significant by day 7 
and 14. All three decellularized matrix treatment groups maintain elevated levels of 
CD4+ T helper cells at 7 and 14 days post-surgery suggesting a prolonged T helper 
response due to the peptides or danger signals present in the decellularized matrix, and 
those antigens being potentially “remembered” by the adaptive immune response. 
When comparing the percentage of local T cells positive for CD4+ in the bone marrow 
of the secondary surgery groups to primary surgery groups there is a trend toward 
increased activation in secondary treatments.  
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Local Adaptive Immune Response 
To measure the local adaptive immunity, B cells (Figure 13) and CD4+ sub-
groups were stained in the right lymph node nearest the surgery site. Similarly to the 
local response, T cell activation was measured in the right lymph nodes as well. In a 
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Figure 10: Local changes in T cell populations in the Bone Marrow 
between treatments in the secondary surgery groups (n=3) at 3, 7 and 14 
days post-surgery. Th signifies T helper cell groups (CD4+) while Tc signifies 
cytotoxic T cell (CD8+) groups # p<0.05 vs control, @ vs. GelMA 
treatment, & vs. Liver treatment, % vs. Lung treatment.  
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similar trend as previously reported, CD4+ and CD8+ T cell populations were 
significantly elevated in the decellularized matrix groups in comparison to the GelMA 
and control groups (Figure 11). These elevated levels were maintained in the lymph 
node through 3 and 7 days post surgery for single surgery groups. Secondary surgery 
groups followed a similar trend (Figure 12). At 3 and 7 days post surgery, CD4+ cells 
were extremely elevated, reaching levels extensively higher than in the primary surgery 
group. This could be due to communication with antibodies produced by t effector or B 
cells which constitutes the memory response of the adaptive immunity.  
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Figure 11: Local changes in T cell populations in the right lymph node between single 
surgery treatment groups (n=3) at 3 and 7 days post-surgery. Th signifies T helper cell 
groups (CD4+) while Tc signifies cytotoxic T cell (CD8+) groups. # p<0.05 vs control, @ 
vs. GelMA treatment, & vs. Liver treatment, % vs. Lung treatment. 
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2nd Surgery Right Lymph Node 
Figure 12: Changes in T cell populations in the right lymph nodes between secondary 
surgery treatment groups (n=3) at 3, 7 and 14 days post-surgery. Th signifies T helper 
cell groups (CD4+) while Tc signifies cytotoxic T cell (CD8+) groups. # p<0.05 vs control, 
@ vs. GelMA treatment, & vs. Liver treatment, % vs. Lung treatment. 
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To look into more specifically how the T helper cells are influencing the immune 
response and local microenvironment, T helper cell populations were stained for four 
primary subsets: Th1, Th2, Th17, and Treg. In the first study consisting of one single 
surgery, Th1 and Th17, classically considered pro-inflammatory T helper cell subsets 
see significant increases in activation in all decellularized matrix groups in comparison 
to the GelMA and control. This is maintained through seven days in all groups, with Th1 
levels in the lung treatment group reducing lower levels, though maintain a significant 
increase compared to the control. This would suggest that the hydrogel constructs, as 
well as the surgeries themselves would shift the CD4+ T helper cells toward a pro-
inflammatory response via Th1 and Th17 activation (Figure 14). Generally this response 
then seems to shift back toward anti-inflammatory as Treg subpopulations increase 
dramatically between day 3 and 7 post surgery, and Th17 levels begin to drop off.  
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1st Surgery Right Lymph Node 
3 Day 7 Day 
Figure 14: Changes in T helper cell populations in the lymph node between 
single surgery treatment groups (n=3) at 3 and 7 days post-surgery. Following 
CD4% selection, transcription factor staining for Tbet (TH1), Gata3 (TH2), RORγt 
(TH17) and Foxp3 (Treg) identified T helper cell subsets. # p<0.05 vs control, @ 
vs. GelMA treatment, & vs. Liver treatment, % vs. Lung treatment. 
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In the secondary surgery groups, T helper cell populations follow a similar trend 
as was discussed previously though delayed. At 3 and 7 day post secondary surgery, 
pro-inflammatory Th1 and Th17 subsets are increasing dramatically and reaching their 
peak at 7 days (Figure 15). Previously in single surgery groups, extracellular matrix 
treatment groups reached their highest increase at day 3, and begin reducing with 
elevated Treg ctivation at 7 days. For secondary surgery groups, pro-inflammatory T 
helper cells did not begin attenuating until day 14, at which point Treg activation is 
increased dramatically. This overall trend suggests that the secondary treatment groups 
are extending the pro-inflammatory response, and shifting the CD4+ T helper cells 
primarily toward Th1 and Th17 phenotypes. The Th1 phenotype is the prime driver of 
the positive inflammatory feedback loop through interferon-γ secretion. Th17 is 
classically known as a link between adaptive and immune systems, and a driver of the 
pathogenesis of multiple autoimmune disorders [44], [45]. The increased prevalence of 
pro-inflammatory Th17 cells also induce the activation and proliferation of B cells 
(Figure 13). These B cells can then provide antibodies to the antigen or go dormant as 
memory cells.  
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2nd Surgery Right Lymph Node 
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Figure 15: Changes in T helper cell populations in the lymph node between secondary surgery treatment groups 
(n=3). Following CD4% selection, transcription factor staining for Tbet (TH1), Gata3 (TH2), RORγt (TH17) and Foxp3 
(Treg) identified T helper cell subsets. # p<0.05 vs control, @ vs. GelMA treatment, & vs. Liver treatment, % vs. Lung 
treatment. 
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1st Surgery Right Lymph Node 2nd Surgery Right Lymph Node 
Figure 13: Changes in B cell populations in the right lymph node between single and 
secondary surgery treatment groups (n=3) at 3, 7 and 14 days post-surgery through 
CD19+ staining selection. # p<0.05 vs control, @ vs. GelMA treatment, & vs. Liver 
treatment, % vs. Lung treatment. 
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Systemic Adaptive Immune Response 
In addition, similar studies were conducted in the spleen to measure the systemic 
adaptive immune response. All treatment groups showed elevated levels of CD3+ T 
cells in the spleen in both single and secondary surgery groups. The number of T cells 
then increases over time, with increases from 3 to seven days in each surgery group. 
This increase is not seen with the GelMA treatment, further solidifying the proteins in the 
decellularized matrix as the driving force of the T cell activation. In the same trend as 
seen int the pervious study, CD4+ and CD8+ T cell populations were significantly 
elevated in the decellularized matrix groups in comparison to the GelMA and control 
groups at 3 and 7 days post-surgery for single surgery groups (Figure 16).  Secondary 
surgery groups see greater increases in T helper cells comparatively, and while reduced 
the T helper cell activation is maintained through 14 days post secondary surgery in the 
decellularized matrix treatments (Figure 17).  
 
 
 
 
 
 
 
 
Kegan Sowers 
50 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1st Surgery Spleens 
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Figure 16: Changes in T cell populations in the spleen between single surgery 
treatment groups (n=3) at 3 and 7 days post-surgery. Th signifies T helper cell groups 
(CD4+) while Tc signifies cytotoxic T cell (CD8+) groups. # p<0.05 vs control, @ vs. 
GelMA treatment, & vs. Liver treatment, % vs. Lung treatment. 
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2nd Surgery Spleens 
Figure 17: Changes in T cell populations in the spleen between secondary surgery 
treatment groups (n=3) at 3, 7 and 14 days post-surgery. Th signifies T helper cell 
groups (CD4+) while Tc signifies cytotoxic T cell (CD8+) groups. # p<0.05 vs control, 
@ vs. GelMA treatment, & vs. Liver treatment, % vs. Lung treatment. 
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Systemically, there is a slight shift in the populations in the subsets of the T 
helper cells. In the lymph node, the Th17 cell populations begin to reduce by 7 days 
post initial surgery, however systemically these levels are maintained or even further 
elevated in the 7 day time point in all treatment groups (Figure 18).  This can be 
attributed to the delay in communication of adaptive immune cells and recruitment from 
the spleen. In the secondary surgery groups, Th17 increases rapidly from day 3 post 
surgery to day 7 post surgery before reducing as the phenotype shifts toward Th2 at 14 
days (Figure 19).  
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1st Surgery Spleens 
3 Day 7 Day 
Figure 18: Changes in T helper cell populations in the spleen between single 
surgery treatment groups (n=3) at 3 and 7 days post-surgery. Following CD4% 
selection, transcription factor staining for Tbet (TH1), Gata3 (TH2), RORγt (TH17) 
and Foxp3 (Treg) identified T helper cell subsets. # p<0.05 vs control, @ vs. 
GelMA treatment, & vs. Liver treatment, % vs. Lung treatment. 
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2nd Surgery Spleens 
3 Day 7 Day 14 Day 
Figure 19: Changes in T helper cell populations in the spleen between secondary surgery treatment groups (n=3). 
Following CD4% selection, transcription factor staining for Tbet (TH1), Gata3 (TH2), RORγt (TH17) and Foxp3 (Treg) 
identified T helper cell subsets. # p<0.05 vs control, @ vs. GelMA treatment, & vs. Liver treatment, % vs. Lung 
treatment. 
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Conclusion 
In vitro analysis showed the potential of antigen presentation of digested proteins 
from decellularized matrices in the activation of CD4+ T helper cells and subsequent 
proliferation. When applied to the in vivo setting through medullary cavity injection, 
decellularized extracellular matrices produced an inflammatory reaction toward the M1 
macrophage phenotype, that was mostly resolved over 7 days denoted by increases in 
M2 macrophage phenotypes. When the animals were subjected to secondary surgeries 
three weeks following their initial surgery, the inflammatory profile was increased, and 
seemed to linger beyond the 7 day mark. While this could be attributed solely to the 
second surgery itself, GelMA groups without decellularized matrices additives showed 
attenuation of this inflammatory response, with M1 phenotype macrophages reducing to 
near control levels in the bone marrow. The decellularized matrix treatment groups 
showed a sustained M1 macrophage phenotype in the bone marrow cavity persisting for 
14+ days following secondary surgery. This increase in sustained inflammation may be 
due to a memory response from the adaptive immune system as similar peptides and 
danger signals activate the CD4+ T helper cell response.  
This trend was followed when T cell populations were identified in the bone 
marrow as well as local lymph node. Secondary surgery groups showed persistent 
elevated levels of CD4+ T helper cells in the bone marrow in comparison to the single 
surgery groups. Right lymph node CD4+ T helper cell populations also showed 
increases in the secondary surgery group in comparison to the primary surgery group, 
as would be expected. Interestingly, CD8+ cytotoxic T cells showed elevated levels in 
the secondary surgery groups when compared with the single surgery groups. This 
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would not be expected, as CD8+ Cytotoxic T cells are generally activated by MHC I 
antigen presentation, however Th1 subsets of CD4+ T cells produce interferon-γ which 
stimulates the CD8+ activation in a positive feedback loop. The secondary surgery 
groups showed elevated levels of Th1 populations in both the local (lymph node) as well 
as systemic (spleen) CD4+ populations. In addition to elevated Th1 populations, the 
secondary surgery groups had elevated levels of Th17 populations which greatly 
influence the adaptive immune response. Th17 cells are one of the primary modulators 
in autoimmunity, and increases in Th17 activity as well as IL-17 production denote an 
extremely pro-inflammatory setting buoyed by antigen memory in CD4+ activation. 
When subjected to multiple treatments of decellularized extracellular constructs, the 
lengthened and heightened inflammatory response mediated by elevated Th1 and Th17 
levels indicates that the repeated treatments of digested extracellular matrices provided 
the antigens to influence the adaptive immune response, and provide a short-term 
memory response. Overall, this suggests that when choosing the methodologies of 
processing of decellularized matrices, further testing is needed to ensure that the 
adaptive immune response to broken down peptides is minimized.  
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